Agnieszka Boesen

Array ( [id] => 6372567 [patent_doc_number] => 20100080775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'RECOMBINANT ADENOVIRUSES ENCODING THE SPECIFIC IODINE TRANSPORTER (NIS)' [patent_app_type] => utility [patent_app_number] => 12/567076 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9825 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080775.pdf [firstpage_image] =>[orig_patent_app_number] => 12567076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479077 [patent_doc_number] => 20100285132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/562432 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 17275 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285132.pdf [firstpage_image] =>[orig_patent_app_number] => 12562432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174704 [patent_doc_number] => 20110177163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A' [patent_app_type] => utility [patent_app_number] => 13/119583 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7386 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177163.pdf [firstpage_image] =>[orig_patent_app_number] => 13119583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372802 [patent_doc_number] => 20100080817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/552064 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8290 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080817.pdf [firstpage_image] =>[orig_patent_app_number] => 12552064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087929 [patent_doc_number] => 20110217307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'SYNTHETIC PEPTIDES CORRESPONDING TO OVERLAPPING NEUTRALIZING DETERMINANTS IN THE CBD1 EPITOPE INDUCE BROADLY NEUTRALIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/061035 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35342 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217307.pdf [firstpage_image] =>[orig_patent_app_number] => 13061035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397352 [patent_doc_number] => 20090317415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'HPV VACCINE COMPRISING PEPTIDES FROM HOST CELL PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/538382 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12258 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317415.pdf [firstpage_image] =>[orig_patent_app_number] => 12538382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575080 [patent_doc_number] => 20100129389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/534658 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 25276 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129389.pdf [firstpage_image] =>[orig_patent_app_number] => 12534658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6347612 [patent_doc_number] => 20100330650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS [JEV] INFECTION AND A METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/497217 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330650.pdf [firstpage_image] =>[orig_patent_app_number] => 12497217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497832 [patent_doc_number] => 20100010193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Immunogenic complexes and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 12/458116 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 11978 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010193.pdf [firstpage_image] =>[orig_patent_app_number] => 12458116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254645 [patent_doc_number] => 20100028922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO BENZOFURANS, AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/493736 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26321 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028922.pdf [firstpage_image] =>[orig_patent_app_number] => 12493736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602002 [patent_doc_number] => 20100322963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'LOW DOSE INOCULATION WITH TAP FOR ANTI-TUMOR IMMUNITY' [patent_app_type] => utility [patent_app_number] => 12/487019 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6500 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322963.pdf [firstpage_image] =>[orig_patent_app_number] => 12487019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374966 [patent_doc_number] => 20090312527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Novel monoclonal antibodies against HPV proteins' [patent_app_type] => utility [patent_app_number] => 12/456053 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16084 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312527.pdf [firstpage_image] =>[orig_patent_app_number] => 12456053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831054 [patent_doc_number] => 08859218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'In situ detection of early stages and late stages HPV infection' [patent_app_type] => utility [patent_app_number] => 12/456054 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 39 [patent_no_of_words] => 20853 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12456054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588291 [patent_doc_number] => 20100061965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'RESPIRATORY SYNCYTIAL VIRUS RENDERS DENDRITIC CELLS TOLEROGENIC' [patent_app_type] => utility [patent_app_number] => 12/479253 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 8603 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061965.pdf [firstpage_image] =>[orig_patent_app_number] => 12479253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302878 [patent_doc_number] => 20090297530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'HERV-K ANTIGENS, ANTIBODIES, AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/475009 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 98 [patent_figures_cnt] => 98 [patent_no_of_words] => 40425 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297530.pdf [firstpage_image] =>[orig_patent_app_number] => 12475009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5489090 [patent_doc_number] => 20090290161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'METHOD AND DEVICE FOR EXPRESS ANALYSIS OF ACETONE TRACES IN GASES' [patent_app_type] => utility [patent_app_number] => 12/471935 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3803 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0290/20090290161.pdf [firstpage_image] =>[orig_patent_app_number] => 12471935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11183624 [patent_doc_number] => 09415006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same' [patent_app_type] => utility [patent_app_number] => 12/472223 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 14 [patent_no_of_words] => 45802 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12472223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495324 [patent_doc_number] => 20090263352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS' [patent_app_type] => utility [patent_app_number] => 12/470336 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39393 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263352.pdf [firstpage_image] =>[orig_patent_app_number] => 12470336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118631 [patent_doc_number] => 20110076304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS' [patent_app_type] => utility [patent_app_number] => 12/993803 [patent_app_country] => US [patent_app_date] => 2009-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18341 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076304.pdf [firstpage_image] =>[orig_patent_app_number] => 12993803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742345 [patent_doc_number] => 20120020998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PLASMACYTOID DENDRITIC CELL LINE USED IN ACTIVE OR ADOPTIVE CELL THERAPY' [patent_app_type] => utility [patent_app_number] => 12/993076 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10202 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020998.pdf [firstpage_image] =>[orig_patent_app_number] => 12993076 [rel_patent_id] =>[rel_patent_doc_number] =>)